274 results on '"Hodge, Rachel A."'
Search Results
2. The septate junction component bark beetle is required for Drosophila intestinal barrier function and homeostasis
3. Mechanisms of Germline Stem Cell Competition across Species.
4. Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
5. Age-related decline of occluding junctions in Drosophila melanogaster
6. Supplementary Figure S5 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
7. Supplementary Table S2 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
8. Data from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
9. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
10. EGFR Mutation Analysis for Prospective Patient Selection in Two Phase II Registration Studies of Osimertinib
11. Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer
12. Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer
13. Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
14. Prevalence of incidental germline variants detected via tumor-only mesothelioma genomic profiling
15. Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFRMutant Non–Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in VitroDiagnostic
16. Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice
17. Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
18. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
19. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 ( IMPA2) gene and bipolar disorder
20. A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
21. Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress
22. Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)
23. A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective COX-2 Inhibitor, GW406381, in Patients With Postherpetic Neuralgia
24. Premature Dissolution of the Microsporocyte Callose Wall Causes Male Sterility in Transgenic Tobacco
25. Human Sex-Specific Synaptic Adhesion Proteins NLGN4X and NLGN4Y Regulate the Dual Innervation of Dendritic Spines
26. Literacy, Lives and Learning
27. Preparation of RNA Dot Blots
28. Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer
29. Clinical performance of a comprehensive novel liquid biopsy test for identifying non-small cell lung cancer (NSCLC) patients for treatment with osimertinib.
30. The highly expressed tapetum-specific A9 gene is not required for male fertility in Brassica napus
31. 15. Photography in collaborative research on multilingual literacy practices: images and understandings of researcher and researched
32. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC
33. A Pilot investigation of mild hypothermia in neonates receiving extracorporeal membrane oxygenation (ECMO)
34. The isolation and characterisation of the tapetum-specific Arabidopsis thaliana A9 gene
35. Cloning and sequencing of a cDNA encoding the major storage proteins of Theobroma cacao: Identification of the proteins as members of the vicilin class of storage proteins
36. Patterns of gene expression in developing anthers of Brassica napus
37. Cloning and sequencing of the cDNA encoding the major albumin of Theobroma cacao: Identification of the protein as a member of the Kunitz protease inhibitor family
38. Preparation of RNA Dot-Blots
39. Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
40. Hybridization and detection of digoxigenin probes on RNA blots
41. Estimating long-term survival of previously untreated patients with EGFR mutation-positive (EGFRm) advanced non-small cell lung cancer (NSCLC) who received osimertinib in the FLAURA study.
42. Early clearance of plasma EGFR mutations as a predictor of response to osimertinib and comparator EGFR-TKIs in the FLAURA trial.
43. cDNA Cloning and Screening
44. The Arabidopsis MALE STERILITY 2 protein shares similarity with reductases in elongation/condensation complexes
45. A novel self-organizing embryonic stem cell system reveals signaling logic underlying the patterning of human ectoderm
46. Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset
47. CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
48. CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non–Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)
49. Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
50. Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.